Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humalog Mix 50/50 vs Human Insulin Mix 50/50 in Diabetes
NCT00191581Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin lispro in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: 2-hour Postprandial Blood Glucose Excursion. Started Mar 2005; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00191581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191581.